Premium
Glycaemic control modifies the haptoglobin 2 allele‐conferred susceptibility to coronary artery disease in Type 1 diabetes
Author(s) -
Costacou T.,
Evans R. W.,
Orchard T. J.
Publication year - 2016
Publication title -
diabetic medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.474
H-Index - 145
eISSN - 1464-5491
pISSN - 0742-3071
DOI - 10.1111/dme.13127
Subject(s) - medicine , hazard ratio , coronary artery disease , myocardial infarction , diabetes mellitus , type 2 diabetes , cardiology , haptoglobin , incidence (geometry) , prospective cohort study , confidence interval , endocrinology , physics , optics
Aims We aimed to assess whether the association of the haptoglobin 2 allele with coronary artery disease is modified by glycaemic control in a prospective cohort study of individuals with childhood‐onset Type 1 diabetes. Methods Coronary artery disease events (death from coronary artery disease, confirmed myocardial infarction, stenosis ≥50%, revascularization) were assessed between 1986 and 2013 among 480 individuals with Type 1 diabetes (baseline age 28 years; diabetes duration 19 years). Better glycaemic control was defined as an updated mean HbA 1c during follow‐up of <8% (64 mmol/mol). Results In crude models, the incidence of coronary artery disease increased with the number of haptoglobin 2 alleles (hazard ratio 1.34, 95% CI 1.05–1.71). This association was more pronounced in those with better than in those with worse glycaemic control ( P interaction = 0.05) and remained essentially unaltered after multivariable adjustments (hazard ratio 2.65, 95% CI 1.30–5.41 in those with better glycaemic control and hazard ratio 1.20, 95% CI 0.93–1.56 in those with worse glycaemic control). Conclusions These results suggest that, although better control may reduce the incidence of coronary artery disease in Type 1 diabetes, a residual risk related to the haptoglobin 2 allele remains.